Am J Transplant, Volume 22, Suppl 3 Archives - Page 95 of 190 - ATC Abstracts

2022 American Transplant Congress
Real World Experience Utilizing Donor Kidneys at Risk for Acute Kidney Injury with Belatacept Based Maintenance Immunosuppression
B. Sirandas, A. Chan, M. Eiting, T. Larson, C. Truax, L. Smith
University of Utah Health, Salt Lake City, UT
*Purpose: The demand for kidney transplant continues to rise, and limited supply has encouraged acceptance of marginal donor organs, such as those at risk for…
2022 American Transplant Congress
Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study
T. Ivanics¹, D. So², M. P. Claasen³, D. Wallace⁴, M. Patel⁵, A. Gravely⁶, K. Walker⁷, T. Cowling⁷, L. Erdman⁸, G. Sapisochin³
¹University of Toronto - University Health Network, Toronto, ON, Canada, ²The Centre for Computational Medicine, The Hospital for Sick Children, Toronto, ON, Canada, ³Multi-organ transplant program, University Health Network, Toronto, ON, Canada, ⁴Department of Health Services Research and policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, ⁵Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX, ⁶Multi-organ transplant program, University of Toronto - University Health Network, Toronto, ON, Canada, ⁷Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom, ⁸The Centre of Computational Medicine, The Hospital for Sick Children, Toronto, ON, Canada
*Purpose: National liver transplant (LT) registries are curated in many countries. We compared data from three national registries and developed machine learning algorithm (MLA)-based models…
2022 American Transplant Congress
De-Novo Belatacept Therapy is Associated with Higher Levels of BK Viremia and Lower Rates of BK Clearance in Kidney Transplantation Patients
G. Petrossian¹, J. Ortiz², K. Addonizio¹, L. Teixeira¹, A. Hsiao¹, R. James³, N. Koizumi³, S. Patel⁴, D. Conti², R. Plews²
¹Albany Medical Center, Albany, NY, ²Division of Renal and Pancreatic Transplant Services, Albany Medical Center, Albany, NY, ³George Mason University, Fairfax, VA, ⁴UMC Las Vegas, Las Vegas, NV
*Purpose: To compare the incidence and severity of BK viremia in kidney transplantation patients with a de-novo belatacept (bela) vs. a no-bela maintenance immunosuppression regimen.*Methods:…
2022 American Transplant Congress
Comparison of Outcomes and Management of COVID Infection Among Kidney Transplant Recipients Between Pre-Vaccination Rollout Era and Post-Vaccination Rollout Era
G. Uehara¹, K. Soliman², V. Rao², M. Casey², D. Taber³, M. Posadas Salas²
¹Medical University of South Carolina, Charleston, SC, ²Nephrology, Medical University of South Carolina, Charleston, SC, ³Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: The COVID pandemic has posed a significant challenge among kidney transplant recipients (KTR) due to their immunocompromised states. The effects of COVID vaccination on…
2022 American Transplant Congress
A Nationwide, Multi-Center Survey of Lipid Management Strategies in Kidney Transplant Recipients
J. Pandav, R. Saranu, S. Muhsin, Z. Solhjou, J. Y. Choi, S. Gabardi, A. Chandraker
Renal division, Brigham and Women's Hospital, Boston, MA
*Purpose: KDIGO 2013 guidelines for the management of lipid transplant recommend the use of statins in all kidney transplant recipients (KTRs), but with weak evidence…
2022 American Transplant Congress
Direct Health Care Costs Before and After Kidney Transplantation in Germany – A Longitudinal Analysis Based on Claims Data
S. Ronicke¹, K. Budde¹, D. Schmidt², W. Düttmann¹, M. G. Naik¹, C. J. Wagner³, J. Freitag³, B. Osmanodja¹
¹Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany, ²Buisiness Unit IT, Charité - Universitätsmedizin Berlin, Berlin, Germany, ³AOK Nordost Statutory Health Insurance Fund, Berlin, Germany
*Purpose: Kidney transplantation can improve long-term survival and quality of life in transplant candidates with end-stage renal disease and has shown to have long-term economic…
2022 American Transplant Congress
Attitudes Regarding COVID-19 Vaccine and Vaccine Hesitancy in an Inner-City Kidney Transplant Recipients (KTRs)
E. Bae, L. Wei, C. Canning, S. Martinez-Machado, J. Lee, L. Patel, M. Markell
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: KTRs comprise a high-risk group for COVID-19 infection due to comorbidities and immunosuppression. Studying how vaccination hesitancy in inner-city KTRs has changed since the…
2022 American Transplant Congress
Impact of the Second Year COVID-19 Pandemic on the U.S. Kidney Transplantation: Interrupted Time Series Analysis
E. Tantisattamo¹, N. Polpichai², P. Mutirangura³, M. Tanariyakul⁴
¹Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, ²Faculty of Medicine Songklanagarin Hospital, Prince of Songkla University, Songkhla, Thailand, ³Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, ⁴Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
*Purpose: The number of kidney transplant (KT) was decreased since the COVID-19 pandemic; however, the magnitude of the pandemic on the number of U.S. KT…
2022 American Transplant Congress
No Difference in Graft Survival Among Low Socioeconomic Kidney Allograft Recipients
A. Desai¹, S. Akkina¹, K. Cmunt², D. Jain¹, R. Garcia-Roca³
¹Transplant Nephrology, Loyola University Medical Center, Maywood, IL, ²Gift Of Hope Community Foundation, Itasca, IL, ³Transplant Surgery, Loyola University Medical Center, Maywood, IL
*Purpose: Low socioeconomic status remains a barrier in access and equity in kidney transplantation with limited data assessing post-transplant outcomes. Alternative options to transplantation include…
2022 American Transplant Congress
Kidney Transplant Professionals’, Recipients’ and Caregivers’ Perspectives on the Use of Precision Medicine in Kidney Transplantation
F. Ballesteros Gallego¹, A. Affdal¹, M. Malo², R. Sapir-Pichhadze³, M. Fortin¹
¹CRCHUM, Montreal, QC, Canada, ²University of Montreal, Montreal, QC, Canada, ³McGill University, Montreal, QC, Canada
*Purpose: Kidney transplantation is the optimal treatment for end-stage kidney disease. However, antibody-mediated rejection can lead to graft loss. The use of Precision Medicine (PM)…